Ten-year dynamics of risk factors and total cardiovascular risk in а cohort of male intellectual workers
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Aim. To study the prevalence of cardiovascular disease (CVD) risk factors (RFs), to evaluate the dynamics of RFs and total CVD risk during 10-year ambulatory follow-up of a cohort of male intellectual workers.
Material and methods. The study included 174 males (mean age 48,9±4,9 years), initially free from diabetes mellitus (DM) or coronary heart disease (CHD). Seven main CVD RFs were studied - family CVD history, hypercholesterolemia (HCH), arterial hypertension (AH), overweight and obesity, smoking, excessive alcohol consumption - as well as two additional RFs - elevated heart rate (HR) and electrocardiography signs of left ventricular hypertrophy (LVH). Ten-year dynamics of most prevalent RFs and their combinations was evaluated. Ten-year dynamics of total CVD risk was assessed by European SCORE model.
Results. During 10-year follow-up, the prevalence of main CVD RFs significantly increased: for AH by 40,2 %, for overweight and obesity - by 35,6 % and 9,2 %, respectively. Prevalence of HCH reduced by 5,8 %, smoking - by 50 %, and excessive alcohol consumption - by 8,6 %. The number of people with elevated HR and ECG signs of LVH had doubled. In 13,8 %, Type 2 DM had developed. At baseUne, isolated CVD RFs were observed in 20,7 %, 10 years later - in 13,2 % only In 10 years, the number of individuals with low total risk decreased by 3 times, while the number of persons with high or very high total CVD risk increased by 2 and 7,8 times, respectively.
Conclusion. Different levels of psychological and physical stress in intellectual and manual workers are reflected by different patterns of CVD RF prevalence. High psycho-emotional stress levels significantly increase AH prevalence. In combination with other RFs, it results in total CVD risk increase, which could not be explained by age-related changes only
About the Authors
N. A. ChepurinaRussian Federation
M. N. Mamedov
Russian Federation
A. D. Deev
Russian Federation
N. V. Кisseleva
Russian Federation
References
1. European Guidelines on cardiovascular disease prevention in clinical practice. 3rd Joint European Societies' Task Force on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardio Vase Prev Rehabil 2003;10(Suppl 1): Sl-78.
2. WHO/Evidence, Information and Policy, 2003.
3. Levi F, Lucchini F, Negri E, et al. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the World. Heart 2002; 88: 119-24.
4. Graham IM, D'Agostino R. Managing cardiovascular risk. Clinical Publishing. Oxford (UK) 2007; 7-41.
5. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet 2004; 364: 937-52.
6. Oganov P.G. Kontseptsiya faktorov riska kak osnova profilaktiki serdechno-sosudistykh zabolevanii. Vrach 2001; 7: 3-6.
7. Shal'nova S.A., Deev AD., Oganov P.F. Faktory, vliyayushchie na smertnost' ot serdechno-sosudistykh zabolevanii v rossiiskoi populyatsii. Kardiovask ter profil 2005; 1: 4-8.
8. Campbell DJ. Why do men and women differ in their risk of myocardial infarction? Eur Heart J 2008; 29: 835-6.
9. Akimova E.V., Smaznov V.Yu., Kuznetsov V.A. i dr. Kurenie, risk serdechno-sosudistoi smerti v muzhskoi kogorte i sotsial'nyi gradient. Profil zabol ukrep zdor 2007; 3: 23-8.
10. Osipova I.V., Zal'tsman A.F., Vorob'eva E.N. i dr. Rasprostranennost' faktorov riska i osobennosti porazheniya organov-mishenei pri stress-indutsirovannoi arterial'noi gipertonii u muzhchin trudosposobnogo vozrasta. Kardiovask ter profil 2006; 2: 10-4.
11. Khaltaev H.F. Effektivnost' trekhletnei profilaktiki faktorov riska IBS. Ter arkhiv 1989; 61(1): 47-51.
12. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology. J Hypertens 2007; 25: 1105-87.
13. Natsional'nye rekomendatsii po diagnostike i korrektsii narushenii lipidnogo obmena s tsel'yu profilaktiki i lecheniya ateroskleroza // Kardiovask ter profil. 2007. T. 6. № 6 S3. S. 5.
14. Chazova I.E., Mychka V. B., Litvin A.Yu., Mamedov M.N. Diagnostika i lechenie metabolicheskogo sindroma. Rossiiskie rekomendatsii // Kardiovask ter profil. 2007. T. 6. № 6 S2.
15. Conroy RM, Pyorala K, Fitzgerald AR, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europa: the SCORE project. Eur Heart J 2003; 24: 987-1003.
16. Shal'nova S.A., Deev AD., Vikhireva O.V. i dr. Rasprostranennost' arterial'noi gipertonii v Rossii. Informirovannost', lechenie, kontrol'. Profil zabol ukrep zdor 2001; 2: 3-7.
17. Konstantinov V.V., Timofeeva T.N., Zhukovskii ES. i dr. Dinamika rasprostranennosti arterial'noi gipertonii sredi muzhskogo i zhenskogo naseleniya Moskvy s 1984 po 2001 g.. Profil zabol ukrep zdor 2002;4:15-9.
18. Oganov RE, Shal'nova S.A., Deev AD. Faktory, opredelyayushchie sostoyanie zdorov'ya naseleniya Rossii po dannym obsledovaniya natsional'noi predstavitel'noi vyborki. Dokl nauch-praktich konf "Aktual'nye problemy profilaktiki neinfektsionnykh zabolevanii". Moskva 1997; 177-8.
19. Strandberg TE, Salomaa W, Vanhanen HT, et al. Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study. British Heart J 1995; 74(4): 449-54.
20. Castelli W, Anderson KA. population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham study. Am J Med 1986; 80(Suppl 2A): 23-32.
21. AndersonKM, OdelPM, Wilson PW, KannelWB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-8.
22. Neaton JD, Wentworth D: Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease: overall findings and differences by age for 316.099 white men. MRFIT Research Group. Arch Intern Med 1992; 152: 56.
23. Shal'nova C.A, Deev AD., Oganov RE Rasprostranennost' kureniya v Rossii. Rezul'taty obsledovaniya natsional'noi predstavitel'noi vyborki naseleniya. Profil zabol ukrep zdor 1998; 3: 9-12.
24. Zhukovskii ES, Glazunov I.S, Deev AD. Kurenie i risk razvitiya IBS. Kardiologiya 1987; 27(1): 11-4.
25. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25(21): 1880-90.
26. Countinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data on 20 studies of 95 783 individuals followed for 12,4 years. Diabetes Care 1999; 22: 233-40.
27. Karpov Yu.A., Shal'nova S.A., Deev AD. Issledovanie PREM''ERA: dostizhenie tselevogo urovnya arterial'nogo davleniya -uspekh v lechenii ishemicheskoi bolezni serdtsa. Kardiovask ter profil 2006; 6: 53-60.
Review
For citations:
Chepurina N.A., Mamedov M.N., Deev A.D., Кisseleva N.V. Ten-year dynamics of risk factors and total cardiovascular risk in а cohort of male intellectual workers. Cardiovascular Therapy and Prevention. 2008;7(7):27-33. (In Russ.)
ISSN 2619-0125 (Online)